Mixed Lymphocyte Culture Determinants, Measles Infection and Multiple Sclerosis2 The term 'histocompatibility system' is used to describe a complex of closely linked genes coding for cell surface structures which make cells from one individual able to recognize and reject grafts from other individuals of the same species.
All vertebrates so far studied have several such systems. In mice, guinea-pigs and menthe species best investigatedone system in each species has been found to be of major importance, the major histocompatibility system. Three types of genes are found as reviewed by Thorsby (1974) :
(1) Loci determining the serologically detectable (SD) or HL-A antigens. (2) Loci determining the lymphocyte-defined determinants (LD) or mixed lymphocyte culture (MLC) determinants.
(3) Loci carrying immune response (Ir) genes which govern the immune response to certain antigens.
The HL-A antigens are defined by serological methods, normally the cytotoxic test using specific antibodies and complement. Such antibodies are usually selected from multiparous women or from multiply transfused individuals. About 40 different alleles belonging to 3 different series, the 1st, 2nd and 3rd series, have been defined.
In contrast to the (SD) HL-A antigens the MLC gene products, the MLC determinants, have so far been detectable only by the in vitro MLC test (Thomsen et al. 1974) . Within the last year it has become possible to type the MLC determinants by using cells homozygous at the MLC locus as stimulating cells in the MLC test (Dupont et al. 1974) , and by international exchange of cells it is now possible to characterize at least ten different MLC determinants in man.
Studies in mice and guinea-pigs have shown that the capacity to develop cellular immunity and IgG antibody production against certain defined antigens is controlled by dominant autosomal genes (Ir genes) (Benacerraf 1974) . These Ir genes are closely linked to the major histocompatibility "Present address: Memorial Sloan-Kettering Cancer Center, New York, USA "This study was aided by the Danish Multiple Sclerosis Foundation and the Foundation for Medical Research in Copenhagen, Greenland and Faeroe Islands region in mice, and some of these Ir genes have been mapped on the chromosome very close to the MLC locus. In man the evidence in favour of the existence of Ir genes is yet scanty and primarily based on linkage studies in families with ragweed hay fever (Levine et al. 1972) .
More circumstantial evidence is the association between preferentially 2nd locus antigens and a variety of human diseases (Ryder et al. 1974) . Within the HL-A region there is a linkage disequilibrium: as an example, a person having HL-A1 at the first locus has a high chance of being HL-A8 at the second locus. This linkage disequilibrium seems to include the MLC locus.
HL-A Antigens and MLC Determinants in Multiple Sclerosis
In multiple sclerosis (MS) several groups of investigators (Arnason et al. 1973 , Bertrams et al. 1972 , Naito et al. 1972 , Jersild, Svejgaard & Fog 1972 , Jersild, Svejgaard, Fog & Ammitzb0ll 1973 have reported increased frequencies of the HL-A antigens 3 and 7. The frequency of HL-A7 is consistently increased from about 25 % in normals to about 40 % in MS patients.
In the Copenhagen study 233 patients with MS have,o far been HL-A types. All patients have been carefully evaluated clinically to ensure a definite diagnosis of MS according to the criteria laid down by Broman et al. (1965) . Table 1 summarizes the data collected up to 1 June 1974. Of the 233 patients 90 (38.6%) have the second series antigen HL-A7. Part of these data have previously been published (Jersild, Hansen, Svejgaard, Fog, Thomsen & Dupont 1973) .
MLC typing for the specific MLC determinant LD-7a was performed in the 48 random MS patients with LD-7a homozygous test cells.
An individual was considered LD-7a positive when his response against the test cells gave a stimulation ratio below 3 or when the relative response was below 30 % of the response to a pool of stimulating cells.
We found that 60 % of the MS patients carried the LD-7a determinant; this is significantly different from the 18 % in random normal individuals. Furthermore all MS patients with HL-A7 were also LD-7a positive, whereas only about half of the normal HL-A7 positive individuals are LD-7a positive. These results have subsequently been confirmed by Thorsby et al. (1974) in a smaller study.
In the lower part of Table 1 we have indicated the relative risk for MS, i.e. the risk of developing the disease for individuals carrying the factor, compared to those lacking it (Svejgaard et al. 1974) . The relative risk for developing MS in HL-A7 positive persons is 1.7, which means that Relative risk ofmultiple sclerosis in HL-A7 positive: 1.7 Relative risk of multiple sclerosis in LD-7a positive: 6.9
The relative risk ofmultiple sclerosis is significantly higher in LD-7a positive (P 0.0025) the chance of getting the disease is increased by 70%. In LD-7a positive individuals the risk is increased by 590%. The difference between these two estimates is significant at the 1 % level, indicating that MS is more strongly associated with LD-7a than with HL-A7.
The clinical course of MS varies from a rapidly progressive form with or without multiple attacks, to a more benign form with slow progression and few or no attacks. In the individual patients this course can be expressed as a progression coefficient calculated by dividing the score of the clinical symptoms by the number of years since the disease was first diagnosed (Fog etal. 1970) .
It was possible to calculate the progression coefficient in 46 of the 48 MLC typed patients. Two patients were excluded because of short duration and difficulty in defining the onset of the disease. The progression coefficient varied from 0.08 to 1.25. When the progression coefficient was compared between the groups LD-7a positive and LD-7a negative MS patients (Fig 1) there seemed to be a correlation between the MLC type and the progression coefficient: the progression was significantly faster in the LD-7a positive patients (P<0.01 by rank sum testing).
Cellular Immunity in MS
The findings of increased antibody titres against measles and other virus antigens in MS patients (Brody et al. 1971 , Ammitzb0ll et al. 1972 , Salmi et al. 1972 ) led to investigations of the cellular immunological reactivity against these antigens (Ciongoli et al. 1973 ). Among the different in vitro tests for cellular immunity we first tried several antigen preparations in the lymphocyte transformation test, but none of the preparations was able to initiate reproducible transformation in controls or in MS patients.
We then applied the Clausen modification of the leukocyte migration test (LMT) (Clausen 1971) using different virus antigens. The results are expressed as a migration index, i.e. the mean area of migration in the antigen-containing culture divided by the mean area of the control culture. An index below I signifies inhibition of migration and is regarded as indicating that the lymphocytes possess cellular immunity against the antigen tested.
The following antigens were used: measles antigen, kindly provided by Dr Mordhost, the State Serum Institute, Denmark (Mordhost et al. 1968 ), parainfluenza from Behringswerke and tuberculin (PPD) from the State Serum Institute, Denmark. All antigens were dialysed against TC-199 before use. Measles and parainfluenza antigens were used undiluted; PPD was used in a concentration of 100 ,ug/ml. Each cell culture was preincubated 45 minutes with 10 pil antigen to 100 pl cell culture. individuals. The results are analysed by unpaired rank sum test. The P-valuesfor measles andparainfluenza are below I x 10-4,for PPD the value is 1.1 x 10-2. For the difference between measles andPPD within the MSpatients the P-value-1.4 x 10-2 measles and parainfluenza antigens in the concentration used. With PPD the difference is less significant. However, it must be pointed out that the controls were not completely matched for age and sex. The difference between measles and PPD within the MS group of patients is significant at the 1 % level. Similar results with measles antigens in MS patients have been reported by Utermohlen & Zabriesky (1973) using the capillary migration system.
Conclusion and Comments
Previous studies in MS have shown raised antibody titres against measles virus, elevated oligoclonal IgG in the spinal fluid (Link 1972) and increased frequencies of the HL-A antigens 3 and 7.
Our studies indicate an even higher association with a certain MLC determinant (LD-7a); the possession of this determinant also seems to influence the clinical course of the disease. The results of the leukocyte migration test suggest a decreased cellular immunity against certain virus antigens, especially measles antigen.
Several explanations for these findings can be given, but with our present knowledge from animal studies about the genetic control of the immune response, it is tempting to suggest that they reflect the existence of one or more Ir genes which, in turn, may be responsible for an altered immunological reactivity against one or more of these virus antigens. This altered response in the host could lead to a persistent virus infection with measles or closely related viruses. Decreased cellular immunity leading to a persistent virus infection would then explain the elevated circulating antibody titres and the raised IgG in the spinal fluid. However, this evidence is still only circumstantial.
Family studies show that the inheritance of MS is likely to be multifactorial. Most individuals with the particular HL-A and MLC make-up do not develop MS, clearly indicating that other factors are involved in the pathogenesis of this disease.
In autumn 1973 we started a pilot study to investigate the possibility of changing the abnormal immunological response of MS patients. Five patients were treated with repeated injections of ultra-filtrated transfer factor, kindly provided by Dr P Grob, Institut fur Medizinische Mikrobiologie, Zurich. In all 5 patients it was possible to convert the negative reaction in the LMT to a 'normal' reaction. The duration of this conversion varied from two weeks to more than two months. In 3 of the 4 patients an increase in the stimulation ratio against the LD-7a homozygous test cells was observed. These results will be published in detail elsewhere .
Since April this year a further 9 patients have started on a therapeutic programme with repeated injections of transfer factor and monthly immunological testings. We hope within a year from now to know whether this treatment is of any clinical benefit or if the changes observed in the immunological parameters are simply another puzzling immunological phenomenon in patients with MS. Dr Platz explained in answer to questions that there was so far no difference in the response to paramyxoviruses in the leukocyte migration assay between those patients who were LD-7a positive and those that were LD-7a negative, though only few of the latter have been tested. He also pointed out that the specifically allergized cells in patients with MS might in fact be sequestered in the brain or elsewhere.
In spite of the curious result that, following transfer factor, one patient had acquired the capacity to respond to LD-7a cells, Dr Platz said family studies showed that his patients were genetically LD-7a positive. No differences in the leukocyte migration tests to measles had been found between normal subjects that were LD-7a positive or negative.
There was some discussion on the epidemiology of multiple sclerosis in relation to its association with the transplantation antigens. Dr Platz said that the association of HL-A 3 and HL-A 7 had also been found in regions other than Scandinavia and thought that studies of the transplantation antigens might be of some predictive value. It was agreed that the relation to transplantation antigens could not explain all the epidemiological features, particularly the observation that one's geographical location in the first decade of life determined the subsequent proneness to MS on a population basis.
During January to June 1974 a series of nine meetings under the title Basis of Therapy was held on topics of current and growing interest to practising clinicians. On each occasion three speakers discussed different aspects of the subject, and a panel discussion followed. The programme was as follows: 
